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a b s t r a c t
Background: This study reports the long-term outcomes of a metaphyseal fit-and-fill cementless femoral
component in total hip arthroplasty (THA) with a follow-up of 15-19 years.
Methods: We conducted a retrospective review of 376 consecutive THAs (345 patients), using a triple
tapered stem performed between 2000 and 2003 with a view to assessing survivorship and radiological
and functional outcomes. Images were assessed for initial alignment, terminal osteolysis, or subsidence,
while clinical outcomes were assessed using the St Michael’s Hip Score.
Results: Forty-five (11.9%) hips were lost to follow-up, 20 (5.31%) had died before our 15-year cutoff
follow-up, and 4 (1.06%) had declined follow-up early on, leaving 307 hips (81.64%, 276 patients)
available for both clinical and radiological follow-up at a minimum of 15 years (range 15-19). The mean
age at the time of operation was 49.6 years (range 19-71) and the cohort included 131 (42.67%) male and
145 (47.23%) female patients. Seven stems (2.28%) were revised: 4 due to periprosthetic fractures, 2 for
periprosthetic joint infection, and 1 for adverse reaction to metal debris at the trunnion. The St Michael’s
Hip Score improved from 14.2 (range 9-23) preoperatively to 22.3 (range 13 to 25) at the last docu-
mented follow-up (P ¼ .000). Kaplan-Meier survivorship with stem revision for any reason as the end
point was 97.70%. Worst-case scenario Kaplan-Meier survivorship, where all lost to follow-up are
considered as failures, was 85.3%. No stem was revised for aseptic loosening.
Conclusion: This triple tapered stem in THA shows excellent survivorship beyond a minimum of 15 years.
© 2020 Elsevier Inc. All rights reserved.
The debate between cemented and uncemented femoral stems
in hip arthroplasty is ongoing. Although the cemented implant was
the only option until the early 1980s and results into the 3rd decade
are excellent, the use of uncemented femoral implants is almost
ubiquitous in North America and rising in the rest of theworld [1,2].
However despite its gain in popularity, published data of cement-
less hip arthroplasty survivorship beyond 15 years remain limited
[3e16].
Analysis of the Joint Registry data in the UK and Australia has
shown that revisions for aseptic loosening in cementless femoral
stems are low, particularly in young patients under the age of 65
years [17].
The Synergy Cementless stem (Smith & Nephew, Memphis, TN)
was introduced in 1996. It is a proximally coated triple tapered
implant (tapered in 3 planes; coronal, sagittal, and axial) and
available in 4 circumferential finishes: porous, hydroxyapatite (HA)
coated, porous and HA, and a grit blasted. It is made of high-
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strength forged titaniumwith a 3 proximal to distal taper. Parallel
and longitudinally arranged proximal anterior and posterior flutes
provide additional stability.
The trunnion taper is 12/14 with a small anteroposteriorly
polished neck to minimize impingement and maximize stability.
Neck angle remains at 131 for both standard and high offset necks.
Proximal pore size is 200 microns. Almost 100% pure HA is sprayed
with 50 microns over a grit-blasted surface. Coating distally is grit-
blasted to promote ongrowth and the bullet shaped tip is polished
to prevent bone growth, aiming to reduce the chances of thigh pain.
This stem achieves initial stability through 3-point fixation, at the
posterior proximal neck, anteriorly midway through the meta-
physis, and at the posterior cortex distally.
There are reports with excellent mid-term [18e22] and more
recently long-term (15 years) survivorship [23,24]. The purpose of
our study is to demonstrate the survivorship of this fit-and-fill
cementless stem in a larger consecutive cohort of patients to add
to the weight of evidence of implant survivorship with a minimum
follow-up at 15 years (15-19).
Method
This is a retrospective review of the records of sequential pa-
tients that received a total hip arthroplasty (THA) using this met-
aphyseal fit-and fill, proximal to distal tapered stem design, from
the year 2000 to 2003. Institutional Research Ethics Board approval
was obtained before the initiation of the study (REB# 18-014c).
All operations were performed at a single institution by 2 senior
authors (J.P.W. and E.H.S,) via the posterolateral approach. The stem
chosen was surgeon’s preference and therefore 2 types were used:
the proximally porous coated by one surgeon (E.H.S.) and the
proximally HA coated by the other (J.P.W.). The acetabular
component was a mixture of 2 shellsdInterfit Reflection and
Reflection SNR (Smith & Nephew)dand 3 liners including ultra-
high-molecular-weight polyethylene (UHMWPE), alumina-
ceramic, and more latterly highly cross-linked polyethylene
(XLPE). All patients were allowed to weight bear as tolerated with
the use of an assistive device, from postoperative day 1, and they
were restricted to no active abduction and flexion beyond 90 of
their operated side for 6 weeks.
The patients were evaluated preoperatively and at 3 weeks, 6
months, annually up to 10 years, and every 5 years after surgery or
recalled as part of this final review. The validated patient-reported
outcomemeasure, the St Michael’s Hospital Hip Score [25,26], was
documented at each visit and X-rays were taken consisting of an
anterior-posterior supine pelvic and cross-table lateral view of the
operated side. Radiological assessment was performed by a
fellowship-trained orthopedic surgeon not involved in the oper-
ations (E.T.) and secondary evaluation and auditing was per-
formed by an attending surgeon (A.A.). X-rays were assessed for
stem implantation alignment (varus, valgus, or neutral as defined
by Khalily and Lester [27]). The angle formed between the medial
endosteal cortex of the femoral shaft and the shaft of the implant
was used to determine the degree of varus angulation. When the
angle was more than 5 then the stem was characterized as varus
or valgus respectively. The morphology of the femoral canal was
defined by the Dorr Classification [28]. All patients (except 4) had
a Dorr A or B classification. During this 3-year period, all other
Dorr C patients were treated with a cemented or fully porous
coated cementless stem.
Stem subsidence was defined as the inferior migration of the
stem of more than 2 mm from the initial postoperative X-ray
Fig. 1. The flow chart of our cohort.
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[29]. It was scored by measuring the vertical distance from the
shoulder of the femoral component to the tip of the greater
trochanter on a calibrated X-ray. Finally, radiological and clinical
complications involving femoral and acetabular components
were noted as well.
Statistical Analysis
Descriptive statistics were created for all outcomes. Data were
collected and analyzed on Microsoft Excel Software (Microsoft
Corporation, Redmond, WA). Survivorship analysis was conducted
by creating Kaplan-Meier survivorship curves. Statistical analysis
was performed using IBM SPSS Statistics, version 16 (IBM, New
York, NY). A Student’s paired t-test was utilized to assess clinical
outcome. P value <.05 was considered statistically significant.
Results
Three hundred seventy-six consecutive THA cases (345 patients)
were performed using this metaphyseal fit-and-fill femoral stem in
Dorr A and B femurs. We identified all of those cases with docu-
mented clinical and radiological data at a minimum of 15 years (15-
19) of follow-up. In total, 69 hips (18.27%, 69 patients) were lost to
follow-up. Twenty (5.31%) patients had died before our 15-year
follow-up cutoff. Four (1.06%) patients declined follow-up at 1, 4,
7, and 7 years respectively, as they moved far from our institution,
but denied any revision of their hip. For the remaining 45 hips, last
follow-upwas less than 3 years postoperatively andwewere unable
to locate them. The flow chart of our cohort can be seen in Figure 1.
In total, 307 (81.64%) hips in 276 patients were available for
clinical and radiological evaluation for a minimum 15-year follow-
up. The mean age was 48.6 ± 11 (range 19-71) at the time of
operation. On hundred forty-five (47.23%) females and 131 (42.67%)
males comprised our cohort. One hundred forty-nine hips (48.53%)
received the proximally porous coated and 158 (51.46%) the prox-
imally HA coated one. Stem offset was determined by preoperative
templating and intraoperative judgment by the treating surgeon.
Therefore 188 hips (61.23%) received a standard offset stem and 119
Table 1





Mean age at surgery (range) 49.6 (19-71)
Door classification (A/B/C) 250/53/4
Diagnosis preoperatively
Osteoarthritis 178






Proximally porous coated Synergy 149
HA coated Synergy 158
Acetabular components
Interfit Reflection cell 138 (45.0%)
Reflection SNR cell 169 (55.0%)
Liners
Alumina-ceramic 94 (30.6%)
Standard (UHMW) polyethylene 172 (56.0%)




HA, hydroxyapatite; UHMW, ultra-high-molecular-weight; XLPE, highly cross-
linked polyethylene.
Fig. 2. KaplaneMeier survivorship curve with stem revision for any reason as end point.
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hips (38.76%) a high offset. To further analyze this, 107 of the 188
standard offset hips (56.91%) were of male patients and 64 of the
119 high offset hips (53.78%) were of female ones.
The 2 acetabular components used were 138 Interfit Reflection
(45%) and 169 Reflection SNR (55%) (Smith & Nephew). Acetabular
liners used were 94 alumina-ceramic (30.6%), 172 UHMWPE
(56.0%), and more latterly 41 XLPE (13.3%). Femoral heads included
103 alumina-ceramic (33.5%) and 204 metal head (66.4%). The
demographic characteristics of our cohort are shown in Table 1.
Seven stems (2.28%) in 7 patients were revised. Four of these
were due to periprosthetic fractures. Two patients were diagnosed
with periprosthetic fractures in the immediate (within days)
postoperative period, either when still hospitalized or recovering at
a rehabilitation center. Two patients were revised at 3 years and 12
years for Vancouver B2 periprosthetic fractures after falls. Both
stems were well fixed and asymptomatic prior to the incident but
were revised to a modular device and cerclage wires.
Two more patients were revised for periprosthetic joint infec-
tion at 3 and 15 years respectively and underwent a 2-stage revi-
sion. Both stems were well bonded and an extended trochanteric
osteotomy was required for extraction.
One patient was revised for fractured ceramic acetabular liner
with an incidental finding of trunnionosis at 16 years. The revision
took place initially for exchange of fractured ceramic liner but the
finding of significant and surprising trunnionosis (Goldberg grade
3) [30] led to stem revision as well.
No stem showed any evidence of subsidence. Thirty stems
(9.77%) were implanted in varus but all survived our last follow-up
of over 15 years, with no clinical evidence of pain documented.
Acetabular revisions occurred in 8 cases (2.6%) for dislocation and
6 cases (1.95%) for significant acetabular osteolysis in Gruen zones 1
and 2 (all associated with UHMWPE). Fourteen cases (4.56%) were
revised with either isolated head and liner exchange for UHMWPE
wear or acute infection. One case (0.32%) was revised by head and
liner exchange for dislocation with a ceramic-on-ceramic bearing.
Mild proximal femoral osteolysis at Gruen zones 1 and 7 was
observed in 31 cases (10.09%) [31,32]. In all 31 cases, an UHMWPE-
metal head coupling was used and there were no associated
symptomaticfindings, therefore regular observationwas continued.
None of the stems associated with an XLPE bearing have any asso-
ciated osteolysis in any femoral or acetabular zone.
In 10 cases (3.25%) of ceramic-on-ceramic coupling, squeaking
had been reported by the patients, at various intervals in follow-up;
however, none of these cases have been revised to date.
The StMichael’sHip Score improved fromameanof14.2 (range9-
23) preoperatively to a mean of 22.3 (range 13-25) at final follow-up
(P ¼ .000).
Kaplan-Meier survivorship with stem revision for any reason as
the end point was 97.70% (Fig. 2), with a mean survival of 18.683
years (95% confidence interval 18.438-18.928). The worst-case
scenario survivorship where all cases lost to follow-up were
considered as failures was 85.30% (Fig. 3), with a mean survival of
16.440 years (95% confidence interval 15.781-17.098).
Discussion
The demand for THA is increasing rapidly along with an aging
population. THA cases are predicted to be doubled by 2030 in the
United States [33]. As a consequence, the revision rates and the
associated social and economic burden will increase as well. One
way to overcome those complications is the use of implants with
proven excellent track record [33].
There are several studies showing good results in the short-term
and medium-term follow-up for this stem [18e22]. However, long-
Fig. 3. Kaplan-Meier survivorship curve with worst-case scenario, where all those patients lost to follow-up were considered as failures.
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term follow-up (minimum of 15 years) is limited [23,24]. In the first
study with a smaller cohort of 85 patients (94 hips), 4 stems were
revised: 1 for aseptic loosening 7 months postoperatively, 1 for a
Vancouver B2 periprosthetic fracture, and 2 for periprosthetic joint
infections. Survivorship with stem revision for aseptic loosening as
end point was 98.9% at 15 years and for any cause was 95.7% [23]. In
a more recent study published in this journal, with a larger cohort
of 210 patients, a total of 4 stems were revised: 1 for subsidence 3
months postoperatively, 2 for periprosthetic B2 fractures, and 1 for
infection. Survivorship with stem revision for aseptic loosening as
end point was 99.5% at 16 years and for any cause was 86.7% [24].
Our results are similar, with 97.70% survivorship for revision for any
cause and no stems were revised for aseptic loosening.
Analyzing the data from the Australian Orthopaedic Association
National Joint Replacement Registry, the cumulative percent for
total hip revision for any reason in all THAs (with osteoarthritis
and developmental dysplasia of the hip as primary diagnosis) at 16
years is 8.8 and 10.8, respectively [2]. More specifically, the revi-
sion rates for the Synergy Reflection coupling at 16 years are 5.8%
(5.1% for the stem and 6.5% for the cup) [34].
Our study adds to the weight of evidence of excellent clinical
and radiological survivorship at the medium to long-term for
cementless femoral implants and further informs the debate over
the cemented femoral implants (especially in the young popula-
tion) [3e17,35,36].
De Martino et al [23], in their radiographic analysis, reported
stress shielding in a number of cases; however, this did not corre-
late with their outcomes and was described as “silent.” This is in
keeping with a previous study with a shorter follow-up period [18].
Only one report found symptomatic stress shielding in the Japanese
population and this involved short stature patients, in whom larger
stems were implanted [37].
Although long-term close observation for the cases that
demonstrated proximal osteolysis is needed, it should be noted that
this phenomenon occurred only when UHMWPE was used. With
the almost exclusive use of XLPE as a bearing surface, this may not
be a concern in the future.
In our study, 9.77% of stems were implanted in varus with no
reported thigh pain and none has been revised to date. Our results
correlate with a mid-term follow-up study (89 patients, 109 hips),
which showed improved scores irrespective of whether the
implant was inserted in perfect position or in varus. Pain and range
of motion were not statistically significant between the 2 groups in
that study [38]. Stress shielding was observed in all cases with
varus alignment and the authors raised their concern about the
effect on the survivorship of the implant in the long term [38]. In
their follow-up of 210 stems, Panichkul et al reported that thigh
pain had increased in incidence (from 2.8% to 3.8%) at 16 years from
their initial 8-year follow-up. But similarly, none of these required
any intervention or affected patients’ quality of life [24].
As it has been previously stated [24], the fit-and-fill design and
the 3-point fixation that characterize this femoral implant allow for
good early fixation and we assert for long-term survivorship.
Our study has several limitations. It is a retrospective report
with no control group for comparison. There was heterogeneity
with mixed acetabular and bearing components. Their inclusion in
the survivorship may affect the overall revision rates. In those cases
where the acetabular components were revised, however, none of
the stems were removed.
Forty-five patients (13%) were lost to follow-up, but this corre-
lates with other studies looking into long-term survivorship of
implants. Furthermore, the majority of our patients treated with
this implant had femoral morphology type Door A and B. Type C
femurs were treated by different implants as per surgeon’s pref-
erence, which constitutes a degree of selection bias.
Finally, radiologic assessment was performed by 2 orthopedic
surgeons; therefore, reliability of the results may be challenged.
However, Engh et al [39] conclude that evaluation of periprosthetic
bone loss on plane radiographs is questionable, since the loss is not
reproducibly recognized until 70% of the bone is gone.
Although 2 recent studies [23,24] published similar results for
their cohort using this fit-and-fill femoral stem, we report the
largest sequential series of implants over 15 years to date, with no
revisions for aseptic loosening of this femoral component.
In conclusion, this fit-and-fill femoral stem, with 3-point fixa-
tion, shows excellent long-term survivorship of 100% with revision
for aseptic loosening as end point and 97.70% with revision for any
reason. The survivorship is irrespective of the stem’s offset and
whether the coating was proximally HA or porous.
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